Athira Pharma Financial Overview
Athira Pharma's market cap is currently $15.26M. The company's EPS TTM is $-1.68; its P/E ratio is -0.40; Athira Pharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
